SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 20.34 |
| Enterprise Value ($M) | 17.04 |
| Book Value ($M) | 23.59 |
| Book Value / Share | 1.00 |
| Price / Book | 0.86 |
| NCAV ($M) | 21.89 |
| NCAV / Share | 0.93 |
| Price / NCAV | 0.93 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.62 |
| Return on Assets (ROA) | -0.41 |
| Return on Equity (ROE) | -0.50 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 6.84 |
| Current Ratio | 6.84 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 25.99 |
| Assets | 27.69 |
| Liabilities | 4.10 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -15.54 |
| Net Income | -15.01 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -13.01 |
| Cash from Investing | 9.06 |
| Cash from Financing | 6.45 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Armistice Capital, Llc | 9.75 | 1.48 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 2,684 | 12,200 | 22.00 | |
| 3,360 | 40,805 | 8.23 | |
| 29,947 | 58,442 | 51.24 | |
| 2,196 | 40,132 | 5.47 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ELEV – Elevation Oncology, Inc. | ELTX – Elicio Therapeutics, Inc. |
| ELUT – Elutia Inc. | ENSC – Ensysce Biosciences, Inc. |
| ENTO – Entero Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io